Transcript Highlights:

• currently going to Mexico for this treatment I began is let me back up to explain what I began is ibogaine

Bills: HB4423, HB3342, HB3645, HB3647, HB3887, HB4430, HB4431, HB2964, HB3834

Keywords: Oklahoma Health Care Authority, Medicaid, immigration verification, healthcare access, federal reporting, health care providers, auditing, patient rights, claims, protection from fraud, audit process, error correction, hospice care, physician determination, healthcare standards, symptom management, health information exchange, all-payer claims database, health care transparency, health care costs

Transcript Highlights:

• Ibogaine puts 86% into remission.
• Kentucky simply cannot afford to not support ibogaine.
• Ibogaine is neither of those.
• Um, but a lot of that is dose dependent, as is ibogaine.
• Um, we have excellent evidence that ibogaine works.

Keywords: 1. Call to Order and Roll Call – 00:00:00 2. Approval of Minutes – 00:01:32 3. Getting to Know the Foundation for a Healthy Kentucky – 00:02:26 4. Healthy Kids Clinic – 00:26:58 5. Pharmacy Payment Parity – 00:56:36 6. Ibogaine – 01:17:37 7. Consideration of Referred Administrative Regulations – 01:53:05 8. Adjournment – 01:53:19, 958, all

Summary: The committee first approved the prior meeting minutes and recognized Eric Clark for his service, noting this may be his last meeting before he leaves state government. The main presentation was from Allison Adams, president and CEO of the Foundation for a Healthy Kentucky, who described the organization’s history, nonpartisan mission, and focus on health equity, prevention, and upstream policy solutions. She said Kentucky’s poor rankings in chronic disease, preventable hospitalizations, and life expectancy show the need to shift resources toward prevention and community-driven strategies rather than relying mainly on treatment after people become sick. Adams emphasized leading health indicators, arguing that lawmakers should track actionable measures such as quit attempts and smoke-free policies instead of only lagging indicators like disease rates and mortality. In response to questions, she said accountability should be shared across communities and systems, with possible incentives and disincentives tied to outcomes, and she supported creating a public data utility or dashboard, ideally with university partners, to help legislators and communities monitor progress. She also cited examples of accountable health community models and said Kentucky could adapt similar approaches. The committee then heard from Meade County Schools Superintendent Mark Martin and district health coordinator Karen Kotche about the Healthy Kids Clinic partnership with Cumberland Health. They described a seven-year effort that led to full implementation in the district, which now has a nurse in every school and a nurse practitioner, allowing services such as sports physicals and other clinic functions to be provided on campus. They said the program has been a strong investment for students and the community and began explaining how the district built the partnership after earlier efforts and delays, including the pandemic.

Transcript Highlights:

• This legislation creates a vehicle for ibogaine, which is a medication that they're developing, deals

Bills: HB2947, HB2964, HB3143, HB3144, HB3342, HB3344, HB3519, HB3522, HB3530, HB3645, HB3647, HB3834, HB4300, HB4422, HB4423

Keywords: behavioral health, Medicaid expansion, clinical interns, mental health services, licensing requirements, medical records, patient rights, privacy, fees, healthcare access, legal claims, medical marijuana, license transfer, Oklahoma Medical Marijuana Authority, moratorium, business regulation, commercial grower licenses, licensing restrictions, agriculture, Medicaid

Bills: HB2947, HB3257, HB3264, HB3834, HB3940, HB3944, HB3979, HB4003, HB4118, HB4326, HB4346, HB4421

Keywords: behavioral health, Medicaid expansion, clinical interns, mental health services, licensing requirements, veterans, disability benefits, federal law, Oklahoma Statutes, military service, criminal justice, minimum sentences, parole eligibility, violent crimes, Oklahoma statutes, HB3834, Oklahoma Breakthrough Therapy Act, ibogaine, ibogaine-based therapeutics, ibogaine analogs

Bills: SB 128, SB 640, SB 672, SB 904, SB 1141, SB 1263, SB 1525, SB 1528, SB 2041, SB 2306, SB 2308, SB 2357, SB 2446, SB 2695, SB 2857, SB 2891, SB 2583

Keywords: hospital reporting, child abuse, neglect, administrative penalty, medical ethics, child protection, hearing instruments, licensing, continuing education, patient protection, medical evaluations, parent-child relationship, Department of Family and Protective Services, adversary hearing, protected rights, legal custody, prescription drugs, prior authorization, neurodegenerative diseases, health benefits

Bills: SB 128, SB 640, SB 672, SB 904, SB 1141, SB 1263, SB 1525, SB 1528, SB 2041, SB 2306, SB 2308, SB 2357, SB 2446, SB 2695, SB 2857, SB 2891, SB 2583

Keywords: hospital reporting, child abuse, neglect, administrative penalty, medical ethics, child protection, hearing instruments, licensing, continuing education, patient protection, medical evaluations, parent-child relationship, Department of Family and Protective Services, adversary hearing, protected rights, legal custody, prescription drugs, prior authorization, neurodegenerative diseases, health benefits

Bills: HB3767, HB3934, HB4199, HB4336, HB2947, HB3834, HB4302, HB4095, HB3287, HB3649, HB4430, HB4431, HB2059, HB3647

Keywords: dentistry, licensing, dental hygiene, foreign-trained dentists, temporary license, public health, emergency response, child care, workforce, pilot program, affordable care, income eligibility, interventional pain management, pain management clinic, chronic pain, acute pain, spinal injections, epidural steroid injection, peripheral nerve block, nerve ablation

Bills: HB3834, HB3940, HB4346, HB2947, HB3257, HB3264, HB4326, HB4421, HB3944, HB3979, HB4118, SCR22, SB169, HB1047, HB2123, HB2650, HB3260, HB3403, SR41, HB3649, HB3742, HB3831, HB3996, HB4321, HB4339

Keywords: HB3834, Oklahoma Breakthrough Therapy Act, ibogaine, ibogaine-based therapeutics, ibogaine analogs, clinical trials, FDA approval, breakthrough therapy designation, opioid use disorder, substance use disorder, traumatic brain injury, mental health, neurological disorders, drug development, public-private partnership, State Department of Health, intellectual property, revolving fund, research funding, medical licensing

Transcript Highlights:

• ><00:06:04.400> including Ibogaine treats all addictions including Ibogaine treats all addictions
• to fund FDA approval for ibogaine. to fund FDA approval for ibogaine.
• Ibogaine is approved by the FDA. Ibogaine is approved by the FDA.
• explain something else about ibogaine. explain something else about ibogaine.
• studies of ibogaine. studies of ibogaine.

Keywords: 958, all

Transcript Highlights:

• I didn't know anything about Ibogaine.
• Ibogaine is a plant-derived substance.
• There are multiple companies that are working with Ibogaine and derivatives of Ibogaine, trying to get
• Where the ibogaine is extracted.
• Ibogaine-assisted therapy.

Bills: HB 44, HB 2200, HB 1612, HB 2747, HB 2038, HB 3717, HB 1431, HB 3800, HB 3801, HB 3560, HB 3246

Keywords: HB 44, Life of the Mother Act, abortion exceptions, medical emergency, reasonable medical judgment, pregnancy complications, maternal health, life-threatening condition, ectopic pregnancy, miscarriage, spontaneous abortion, fetal survival, Texas abortion law, abortion ban, physician liability, health care provider, disciplinary action, aiding and abetting, emergency abortion, obstetric care

Summary: The meeting of the public health committee focused on the pressing issue of opioid addiction in Texas, with a particular emphasis on House Bill 3717. Chairman Harris detailed the bill's intent to fund a grant program for Ibogaine clinical trials, framing it as a critical response to the ongoing opioid crisis. He shared poignant testimonies highlighting the struggles of families and veterans battling addiction and mental health issues. The conversation underscored the necessity of innovative treatments, like Ibogaine, which showed promising results in studies for reducing symptoms of withdrawal and PTSD.

Transcript Highlights:

• I testify on the Ibogaine treatment. I'm a recipient of that particular treatment.
• Ibogaine has significant therapeutic value. It has no propensity for abuse.
• But no one's ever heard of Ibogaine or Ibogaine raves. because there is no recreational.
• Ibogaine has helped these veterans? Absolutely. So.
• Mexico to undergo Ibogaine treatments.

Bills: SB128, SB640, SB672, SB904, SB1141, SB1263, SB1525, SB1528, SB2041, SB2306, SB2308, SB2357, SB2446, SB2695, SB2857, SB2891, SB2583

Keywords: hospital reporting, child abuse, neglect, administrative penalty, medical ethics, child protection, SB 640, Texas Family Code, Department of Family and Protective Services, DFPS, child welfare, foster care, managing conservatorship, suicide attempt, youth suicide, mental health, child protective services, state custody, annual report, reporting requirements

Transcript Highlights:

• Suicidal ideation with ibogaine.
• So why ibogaine?
• Why ibogaine?
• In my own words, this is what ibogaine does.
• "I'm going to assume that drugs like ibogaine...

Keywords: 1182, all

Summary: The Senate Ad Hoc Committee on Access to Breakthrough Mental Health Therapies met to discuss psychedelic-assisted treatments for serious mental health conditions, with a focus on psilocybin, ibogaine, MDMA, and related compounds. The chair framed the issue as a clinical and access problem for veterans, first responders, and others with PTSD, depression, TBI, addiction, and suicidal ideation, emphasizing that these therapies are intended for supervised medical settings rather than take-home use. Members reviewed research claims and policy trends, including FDA breakthrough therapy designations, state-level psychedelic legislation, and the role of Arizona’s right-to-try law in expanding access once federal approval is in place. Testimony came from Alan Mullen, a retired Army Special Forces veteran, who described his PTSD/TBI history and said ibogaine treatment helped him confront trauma and showed promise in reducing symptoms under strict medical monitoring. Dr. Sue Cisley of Scottsdale Research Institute described ongoing FDA-controlled trials in Arizona, said current medications often fail high-need patients, and urged removal of research barriers and preparation for right-to-try and expanded access. Dan Freiberg of the Professional Firefighters of Arizona said firefighters face chronic exposure to trauma, often rely on alcohol or other coping mechanisms, and need effective alternatives beyond traditional therapy. Dr. Chung Trin discussed late-stage psychedelic trials, the FDA breakthrough pathway, safety oversight, and the need for state readiness when approvals occur. Committee members asked about how the treatments work, whether they require psychotherapy support, safety concerns including suicidality and black-market abuse, patenting and synthetic versus natural versions, and costs compared with ketamine and other treatments. Witnesses said the therapies are administered with extensive screening, monitoring, and integration support, and argued that addiction potential appears low under medical supervision. The discussion ended with interest in sending correspondence to federal officials to support right-to-try cooperation and in continuing the research and policy work; no formal vote or action was taken in the portion provided.

Transcript Highlights:

• My name is Brian Hubbard, and I am the executive director of the American Ibogaine Initiative, brought
• Most of us have learned about Ibogaine from either hearing it on the Sean Ryan podcast or the Joe Rogan
• That number is much larger—seeking Ibogaine-assisted therapy.
• Prime, are there any other conditions that ibogaine has shown some effectiveness in treating?
• However, recent events have demonstrated that ibogaine possesses...

Summary: The meeting was a Texas Capitol press event in support of House Bill 3717, which would advance ibogaine research and create a public-private pathway to move the treatment toward FDA approval. Speakers included Brian Hubbard of the American Ibogaine Initiative, Rep. Cody Harris, and VETS co-founders Marcus and Amber Capone. They framed the bill as a chance for Texas to lead on treatment for opioid use disorder, PTSD, traumatic brain injury, and other “diseases of despair,” especially among veterans and their families. Testimony focused heavily on the veteran suicide crisis and personal stories of loss and recovery. Marcus Capone described his Navy SEAL service and said conventional treatments had not been enough for many veterans, while Amber Capone cited VETS’ support for roughly 1,000 veterans and a Stanford collaboration that she said showed large reductions in PTSD, anxiety, depression, and suicidality after ibogaine treatment. Supporters also argued ibogaine may have broader applications, including for other substance use disorders and some neurological conditions, and emphasized the need for research, supervised clinical use, and insurance coverage. No formal committee vote or legislative action was taken in the transcript. The event ended with a brief Q&A and a call for Texas legislators to support HB 3717 and help move the bill forward.

Transcript Highlights:

• Ibogaine raises the remission rate from 30 to 86%.
• Ibogaine raises the remission rate from 30 to 86%.
• The 0.2% risk of death with ibogaine can be mitigated when ibogaine is administered properly.
• The FDA will not expect ibogaine to be 100% safe.
• I prepared to take my first dose of ibogaine.

Keywords: 958, all

Summary: The committee first reviewed preferred administrative regulations and, hearing no concerns, considered them reviewed. It then took up House Bill 388, described as a Casper cleanup bill. The sponsor said it would exempt charitable health care providers from e-prescribing requirements, allow Casper data sharing with certain federal entities, update references to hydrocodone’s schedule status, clean up drafting errors, and clarify practitioner registration with Casper. The bill passed 9-0 and was then approved for consent. Next, House Bill 134 was presented as a follow-up to a prior study on shortages of sexual assault nurse examiners and SANE-ready hospitals. The sponsor and a representative from the Kentucky Association of Sexual Assault Programs said the bill would create a statewide SANE coordinator. The committee adopted a substitute, then passed the bill unanimously and sent it to consent. Senate Bill 147 was then heard as an administrative update to vital records, modernizing certified-copy requests, adjusting fees, and requiring the Cabinet for Health and Family Services to send the annual death report to the State Board of Elections by July 1 each year. It passed unanimously and was also moved to consent. House Bill 280, a Kentucky Board of Nursing cleanup bill, would let the board investigate out-of-state nurses applying for Kentucky licenses, clarify licensing language, and update school rescue medication provisions, including inhalers, nebulizers, glucagon, Solu-Cortef, and nasal epinephrine. A committee substitute narrowed the bill to glucagon updates, and one senator asked whether the bill also covered child care centers; the sponsor said it addressed school medications only but was open to further discussion. The bill passed 10-0 and was reported favorably. Finally, Senate Bill 77 drew extended testimony. The sponsor and supporters argued that ibogaine research and treatment could help address addiction, PTSD, and depression, citing studies, personal recovery stories, and a proposed public-private partnership funded through opioid settlement money. The committee substitute removed the bill’s appropriation request and emergency clause, and members asked questions about whether PTSD is an addiction, whether smoking was included, whether the bill was authorizing research rather than funding, and how the treatment works. The sponsor said the substitute was only creating a structure for research, not appropriating money, and supporters described ibogaine as a one-time, medically supervised treatment. The transcript cuts off before a final vote on Senate Bill 77 is shown.

Transcript Highlights:

• "If you're asking what ibogaine is, ibogaine is a psychoactive alkaloid found in the root bark of the
• We can argue that ibogaine has neither of those characteristics.
• In the early 1970s, ibogaine, along with a number of ..."
• “The bill does not legalize general ibogaine use.
• Coordinating Mississippi trials with multi-state ibogaine trials.

Keywords: Public Health and Welfare - Room 216, 25 February, 2026; 3:00 PM, 925, all

Summary: The committee first handled House Bill 612, which had been laid on the table because of questions about section one. Senator Tate explained that section one would allow the state, counties, and municipalities to enter interlocal agreements to provide installation support services on military installations, mainly road and infrastructure work such as paving and dirt work, and that section two would add Coast Guard medics to an existing provision allowing trained military medics to sit for LPN certification. After questions about the breadth of “installation support services,” the committee adopted the motion for title sufficient, due pass, with opposition noted, and the bill was reported to the Veterans and Military Affairs Committee. House Bill 942 was then passed over at Senator McMahon’s request until Tuesday. The committee then took up House Bill 1034, which would allow terminally ill hospital patients to use medical cannabis gummies. The sponsor said the bill is intended to help terminally ill patients who already qualify for medical cannabis but are denied access in hospitals, and that it prohibits smoking or inhalation. Members raised concerns about whether the bill was too broad, whether it would interfere with hospital and physician judgment, possible drug interactions, federal law issues, liability for hospitals and doctors, storage and disposal requirements, and whether hospitals would incur costs or be forced to handle cannabis on their premises. The sponsor responded that the patient’s use would be logged in the chart, that the caregiver is generally responsible for the lockbox and disposal, and that the bill includes language allowing a facility to opt out if compliance would jeopardize federal funding or licensing. The bill’s author also described the measure as arising from a Coast Guard family’s experience in which a terminally ill patient was denied access to medical cannabis at one hospital but allowed at another, and said the goal is to prevent similar denials for terminally ill patients. He said he was not aware of other drugs treated this way in hospitals, but argued that terminally ill patients should have access to most anything they want. The discussion ended with Senator England asking whether changing the bill’s requirement that a facility “shall” allow medical cannabis to “may” allow it would better protect hospitals and preserve discretion, but no final action on House Bill 1034 was taken in the portion provided.

Transcript Highlights:

• What is ibogaine?
• <00:53:30.080> Ibogaine<00:53:30.480> is<00:53:30.600> a What is Ibogaine?
• Ibogaine is a What is Ibogaine?
• , Ibogaine interacts Pharmacologically, Ibogaine interacts with<00:53:39.240> multiple<00:53:39.640
• > effects, Ibogaine can have side effects, Ibogaine can have side effects, especially<00:54:16.000

Keywords: MS Senate Floor - 5 March, 2026; 10:00 AM, 925, all

Summary: The Senate convened with a quorum, opened with an invocation by Dr. Ryan Wade and the Pledge of Allegiance, and then handled routine business by dispensing with the reading of the journal and committee reports. Several guests were recognized, including Leadership Jackson County, Farm Bureau members, a doctor of the day, adult educators, and other visitors in the gallery. Senator Brumfield also announced support efforts for Senator Warren Barnett, asking members to contribute to him through Ms. Anita Jackson. The chamber then considered a series of House bills, most of them taken up with strike-all amendments and passed by use of the morning roll call. Measures included HB 1390 on personal services funding allocations, HB 1571 on ARPA funds and unexpended balances, HB 1655 on the State Aid Road Construction director’s personnel status, HB 1650 on dormant state accounts and pooled investments, HB 1651 on state agencies using other agencies’ facilities and charging 50% of fair market value, HB 1345 on administrative forfeiture of illegal cigarette and vaping products, HB 1386 on allowing sidewalks as an eligible use of municipal infrastructure funds, HB 671 on alcoholic beverage delivery responsibility ending when retailers transfer possession to delivery services, and HB 1385 on eliminating paper-original homestead exemption submissions. Members asked questions on several bills, especially about whether the fairgrounds language in HB 1651 would affect youth livestock shows and whether HB 1386 or other measures would change county revenue; sponsors generally said the bills were intended to address state-agency use, municipal reporting, or administrative efficiency rather than alter those programs. The Senate also advanced HB 898, creating a sales tax diversion study committee to review misallocated municipal sales tax revenues, assess impacts, examine technology and oversight, and recommend reforms by the 2027 session; Senator Hill questioned whether counties should be included, but the sponsor said that would be a separate policy decision. Later, the Senate reconsidered HB 1265, the Mississippi Debt Management Services Act extended repealer, adopted an amendment to remove the repealer instead of extending it, and then passed the bill. The body also took up SB 2632, the local governments disaster recovery emergency loan program, and voted not to concur and to invite conference. Finally, HB 1142 on bench warrant notices was called up; the sponsor explained a strike-all that would replace certified mail with personal service or electronic transmission and include a reverse repealer for further conference work.

Bills: HB3834, HB3940, HB4346, HB2947, HB3257, HB3264, HB4326, HB4421, HB3944, HB3979, HB4118, SCR22, SB169, HB1047, HB2123, HB2650, HB3260, HB3403, SR41, HB3649, HB3742, HB3831, HB3996, HB4321, HB4339

Keywords: HB3834, Oklahoma Breakthrough Therapy Act, ibogaine, ibogaine-based therapeutics, ibogaine analogs, clinical trials, FDA approval, breakthrough therapy designation, opioid use disorder, substance use disorder, traumatic brain injury, mental health, neurological disorders, drug development, public-private partnership, State Department of Health, intellectual property, revolving fund, research funding, medical licensing

Summary: The Senate convened with a quorum, heard an invocation, and recognized several guests and groups in the gallery, including the Ponca City High School Poe High Steppers, the Edmond Democratic Women, family members of senators, a Grace Reform Baptist Church co-op group, and Oklahoma 4-H participants. The chamber also honored the Red Oak Lady Eagles state championship basketball team with a citation and remarks celebrating their first school basketball title and strong season. The Senate adopted Senate Concurrent Resolution 22, supporting the Lights Out Oklahoma campaign to reduce bird mortality during migration by encouraging reduced exterior lighting in peak migration months. The chamber also adopted Senate Resolution 41, proclaiming April 22, 2026, as the 27th annual 4-H Day at the Capitol, with testimony from 4-H representatives emphasizing youth leadership, civic engagement, and workforce readiness. Several bills passed, including House Bill 169 (house amendments adopted and the bill passed as an emergency measure), House Bill 2123 on the Arkansas River bridge, House Bill 2650 on summary administration estate thresholds, House Bill 3260 on funeral director continuing education approvals, House Bill 3403 on a DEQ/OSU sewage sludge pilot study, House Bill 3649 on the Mental Health Department real property trust, House Bill 3742 on criminal discovery, House Bill 3831 on a Task Force One revolving fund, House Bill 3996 on indigent defense experts in capital cases, House Bill 4321 on limits on retroactive building rule application, and House Bill 4339 on summary administration notice timing. House Bill 1047, which would have authorized a tribal sports betting framework and related revenue distributions, drew extensive debate over gambling addiction, revenue, tribal compacts, geofencing, and NIL funding, but failed 21-27; Senator Coleman gave notice of intent to reconsider. The Senate then announced an Appropriations Committee meeting and adjourned until the next scheduled session.

Transcript Highlights:

• I'm here to underscore one point: ibogaine absolutely deserves to be part of that discussion.
• The human stories around ibogaine treatment are fascinating.
• Now, ibogaine is not a cure-all.
• Let's give ibogaine a fair chance and allow Massachusetts to lead the way. Thank you.
• I traveled to Mexico for a medically supervised retreat using ibogaine and DMT.

Keywords: 995, all

Summary: The hearing opened with remarks from House Chair Mindy Domb and Senate Vice Chair Robyn Kennedy, who outlined procedures for the hybrid public hearing, noted the committee would hear testimony on 15 bills related to treatment settings, and recognized members present. The first major bill discussed was H. 4200, authorizing a pilot program for psychedelic-assisted treatment in licensed facilities. Representative Jim O’Day and witnesses from Control Z supported the bill, describing it as a tightly controlled, medically supervised pilot with DPH oversight, limited sites, and screening requirements. Committee members asked about the number of sites and whether Column Health still existed; witnesses said the bill contemplated three separate pilot programs and that Column Health no longer existed after being purchased by another company. The committee also heard testimony on S. 1405 to make the drug stewardship program permanent by removing its 2026 sunset date. Senator John Keenan and others said the program helps collect and safely dispose of unused medications, reduces diversion, and should remain in place because manufacturers should bear disposal costs. A member from Boston added support based on local concerns about people searching through bags for drugs, and Keenan explained the original sunset reflected pilot status and industry pushback. A large portion of the hearing focused on S. 1394 and H. 2193, which would strengthen implementation of the 2023 Roadmap for Behavioral Health Reform. The Children’s Mental Health Campaign, Parent/Professional Advocacy League, Massachusetts Association for Mental Health, and Elliott Community Human Services testified that the roadmap’s helpline, community behavioral health centers, and crisis services are important but unevenly implemented. They urged a single point of accountability within EOHHS, regular strategic planning, a public data dashboard, and financial analysis of the behavioral health system and the access and crisis intervention trust fund. Witnesses said commercial insurance often does not fully reimburse community behavioral health center services, making sustainability difficult, and asked for better coordination across agencies and crisis response systems. Committee members asked whether the roadmap includes substance use disorder; witnesses said it is intended to cover behavioral health broadly, including mental health and substance use. The committee also heard testimony on bills to ban aversives and on suicide prevention signage. Lisa Jean Graff testified in support of S. 1394 by urging a statewide ban on aversive practices, including electric shock, withholding food or bathroom access, and other painful interventions, arguing disabled people deserve the same protections from harm as others. Fonda Bryant and Carol McLean supported a bill requiring suicide prevention signs on tall parking garages, describing personal experiences and saying the signs could create a brief pause and connect people to 988 or other help. McLean said her son died by suicide from a parking garage and that signage might have made a difference. The committee also heard strong testimony in support of creating intensive stabilization and treatment units within DMH facilities (S. 1398/H. 2204), with the Massachusetts Nurses Association and a DMH nurse arguing that highly assaultive patients need specialized, more secure units to protect staff and other patients and to improve care. Additional testimony supported creating a dedicated board for licensed mental health counselors (H. 4696/S. 1382), with Rep. John Badger, the Mass Mental Health Counselors Association, and others saying LMHCs are a large and growing workforce that needs its own licensing board, clearer standards, and faster implementation of existing licensure reforms. The committee also heard extensive testimony on H. 2223 regarding benzodiazepines and non-benzodiazepine hypnotics. Survivors and advocates described severe withdrawal, lack of informed consent, cognitive harms, and long-term disability, while a physician supported the bill as a way to improve disclosure of risks. Finally, the committee heard multiple witnesses in favor of H. 2231/S. 1383 to establish peer-run respite centers statewide. Advocates and people with lived experience said peer respites provide non-coercive, home-like alternatives to hospitalization, can reduce trauma and repeated admissions, and may be especially important for marginalized communities; they also cited cost savings and existing positive outcomes from current respite programs. No votes or final committee actions were taken during the hearing portion reflected in the transcript.

Transcript Highlights:

• drug, this plant-based medicine, ibogaine, has saved countless lives.
• And it's, particularly with ibogaine, 15 to 24 hours of pretty excruciating pain.
• One promising approach are these therapies like psilocybin and ibogaine.
• One promising approach are these therapies like psilocybin and ibogaine.
• So I'd heard about ibogaine on a podcast.

Summary: The House Committee on Health and Welfare met on April 28 with a quorum and took up several Senate bills, beginning with SB 113 on the local health care provider participation program in Calcasieu Parish. The committee adopted a technical amendment and heard that the bill would shift the local sponsor from the parish to the city if needed by a June 1 deadline. After brief discussion and no opposition, SB 113 was reported favorably with amendments. The committee then approved SB 23, which exempts certain assisted living facilities licensed by LDH from the definition of food service establishment, and SB 150, which would allow LDH to scan and electronically store vital records supporting documents and return originals to citizens. SB 221 also advanced after testimony that it would allow EMS providers to be reimbursed by Medicaid for emergency responses where treatment is provided on scene but the patient is not transported. Members discussed that the bill could reduce unnecessary ER use and likely would require some rulemaking, but it was reported favorably. A major portion of the meeting focused on SB 404, a broad vision benefit plan reform bill. Supporters, including optometrists, said the measure would improve transparency, patient choice, and access to eye care by limiting restrictive plan practices; opponents from the vision care plan industry argued it was an unprecedented, provider-driven overhaul that could raise costs and reduce flexibility. After extensive testimony and an agreed amendment clarifying network participation, the committee reported SB 404 favorably with amendments. The committee also reported SB 32 favorably with amendments after emotional testimony from parents and advocates about perinatal bereavement care, cooling devices, and training for hospitals to give grieving families more time and dignity after infant loss. Finally, the committee heard SB 43, which would create a psychedelic-assisted therapy initiative within LDH for clinical research and treatment involving ibogaine and psilocybin, with testimony from veterans, researchers, and advocates describing potential benefits for PTSD, substance use, and traumatic brain injury. The bill was reported favorably with amendments and set to pass a courtesy sheet. The committee then began SB 253, a bill regulating peptides and compounding pharmacies, adopted technical amendments clarifying provider liability, and continued discussion as the transcript ended.

Transcript Highlights:

• And it's, particularly with ibogaine, it's, you know, 15 to 24 hours of pretty excruciating pain.
• One promising approach is therapies like psilocybin and ibogaine.
• Now, In the last year I've got involved in the Americans for Ibogaine Society or initiative.
• So I'd heard about ibogaine on a podcast.
• And so I traveled outside the country and sat with ibogaine at a clinic known as Beyond.

Bills: SCR37, SB145, SB237

Keywords: informed consent, healthcare, medical procedures, patient rights, surgeon general, regulatory review, adult residential care, generators, emergency power, health safety, Louisiana Department of Health, compliance, regulations, child welfare, Department of Children and Family Services, mandatory reporting, abuse prevention, investigative teams, child ombudsman, forensic interviews

Summary: The House Committee on Health and Welfare met on April 28 with a quorum and took up several health-related bills. SB 113, concerning the local health care provider participation program in Calcasieu Parish, was amended with a technical set and reported favorably with amendments after the author explained it would shift the local sponsor from the parish to the city. SB 23, which exempts certain assisted living facilities from the definition of food service establishment, was reported favorably. SB 150, allowing LDH to scan and return supporting documents for vital records changes, was also reported favorably. SB 221, which would allow EMS providers to be reimbursed by Medicaid for treating patients on scene without transport, drew questions about billing, coding, and implementation but was reported favorably, with members noting it could reduce unnecessary ER use and costs.